P
US6949637B2ExpiredUtilityPatentIndex 48

Methods for diagnosis, prediction and treatment of asthma and other inflammatory conditions based on eotaxin coding sequence polymorphism

Assignee: GEN HOSPITAL CORPPriority: May 16, 1997Filed: Apr 14, 2003Granted: Sep 27, 2005
Est. expiryMay 16, 2017(expired)· nominal 20-yr term from priority
Inventors:LILLY CRAIG MLUSTER ANDREW DDRAZEN JEFFREY M
C12Q 1/6883C12Q 2600/156
48
PatentIndex Score
1
Cited by
6
References
2
Claims

Abstract

Methods and compositions for diagnosing and treating asthma are provided. The methods involve the discovery of a correlation between an eotaxin gene polymorphism and the ocurrence of asthma.

Claims

exact text as granted — not AI-modified
1. A composition comprising an isolated nucleic acid consisting of the wild type normal eotaxin gene sequence as shown in SEQ ID NO: 1, wherein said nucleic acid includes a guanine to adenine substitution 67 base pairs following the ATG initiation codon of the wild type normal eotaxin gene, whereby counting is initiated at the A in that codon. 
     
     
       2. A composition comprising an isolated oligonucleotide consisting of a nucleotide sequence selected from the group consisted of:
                         AGAAACCACCACCTCTCACG;   (SEQ ID NO: 2)         GAGAATTTGCAGTGAGTCTGT;   (SEQ ID NO: 3)         GGGGCTTACCTGGCCCAAC;   (SEQ ID NO: 4)         GGGGCTTACCTGGCCCAAT;   (SEQ ID NO: 5)         and         TCAAGGAAGGTTCTTAGATCG.   (SEQ ID NO. 6).

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.